Competitive binding of Pu and Am bone mineral and novel chelating agents

Radiation Protection Dosimetry

Volumn 105, Issue 1-4, 2003, Pages 527-534

  Guilmette, R A ^a   Hakimi, R ^b   Durbin, P W ^c   Xu, J ^d   Raymond, K N ^c,d  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIDE; AMERICIUM; CATECHOL DERIVATIVE; CHELATING AGENT; HYDROXAMIC ACID DERIVATIVE; HYDROXYCATECHOL DERIVATIVE; PENTETATE CALCIUM; PENTETATE ZINC; PLUTONIUM; PYRIDONE DERIVATIVE; SULFOCATECHOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; BONE MINERAL; CHELATION THERAPY; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BINDING; DRUG EFFICACY; DRUG SPECIFICITY; DRUG STABILITY; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; PHYSICAL CHEMISTRY;

EID: 0141452185     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.rpd.a006297     Document Type: Article

References (26)

1. Guilmette, R. A. Actinide decorporation therapy: past, present and future. In: Seventh Coordination Meeting of World Health Organization Collaborating Centers in Radiation Emergency Preparedness and Assistance Network - REMPAN. Published by Instituto de Radioproteçao e Dosimetria, Av. Salvador Allende s/n, Jacarapagua, Rio de Janeiro, Brazil, CEP 22780-160-CP 37750.
2. Guilmette, R. A., Lindhorst, P. S. and Hanlon, L. L. Interaction of Pu and Am with bone mineral in vitro. Radiat. Prot. Dosim. 79(1-4), 453-458 (1998).
3. 238Pu elimination from mice by poly(catechoylamide) ligands. Radiat. Res. 99, 85-105 (1984).
4. White, D. L., Durbin, P. W., Jeung, N. and Raymond, K. N. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands. J. Med. Chem. 31, 11-18 (1988).
5. 238Pu(IV) from mice by polyatecholate, -hydroxamate or -hydroxypyridinonate ligands. Radiat. Prot. Dosim. 26, 351-358 (1989).
6. 238Pu(IV) in vivo by 3,4,3-LICAM(C): effects of ligand methylation and pH. Health Phys. 56, 839-955 (1989).
7. Xu, J., Kullgren, B., Durbin, P. W. and Raymond, K. N. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pvridinone ligands for in vivo plutonium(IV) chelation. J. Med. Chem. 38, 2606-2614 (1995).
8. Durbin, P. W., Kullgren, B., Xu, J. and Raymond, K. N. Multidentate hydroxypyridonate ligands for Pu(IV) chelation in vivo: comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO. Int. J. Radiat. Biol. 76, 199-214 (2000).
9. Lloyd, R. D. and 12 others. Removal of Pu and Am from beagles and mice by 3,4,3-LICAM(C) 3,4,3-LICAM(S). Radiat. Res. 99, 106-128 (1984).
10. Durbin, P. W., Kullgren, B., Xu, J. and Raymond, K. N. In vivo chelation of Am(III), Pu(IV), Np(V) and U(VI) in mice by TREN-(Me-3,2-HOPO). Radiat. Prot. Dosim. 53, 305-309 (1994).
11. Stradling, G. N., Gray, S. A., Moody, J. V., Hodson, A., Raymond, K. N., Durbin, P. W., Rodgers, S. J., White, D. L. and Turowski, P. N. The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and americium ftom rats. Int. J. Radiat. Biol. 59, 1269-1277 (1991).
12. Stradling, G. N., Hodson, A. and Pearce, M. J. Recent progress in decorporation of plutonium, americium, and thorium. Radiat. Prot. Dosim. 53, 297-304 (1994).
13. Stradling, G. N., Recent developments in the decorporation of plutonium, americium and thorium. Radiat. Prot. Dosim. 79, 445-448 (1998).
14. Kappel, M. J., Nitshce, H. and Raymond, K. N. Complexation of plutonium and americium by catecholate ligands. Inorg. Chem. 24, 605-611 (1985).
15. Neuman, W. F. and Neuman, M. W. Surface chemistry. In: The chemical dynamics of bone mineral (Chicago: University of Chicago Press) pp. 55-100 (1958).
16. 98Mo. II: synthesis and characterization of actinide-specific chelating agents. Thesis. University of California, Berkeley (1996).
17. Xu, J., Radkov, E., Ziegler, M. and Raymond, K. N. Pu(IV) Sequestration: structural and thermodynamic evaluation of the extraordinarily stable Ce(IV) hydroxypyridinonate complexes. Inorg. Chem. 39, 4156-4164 (2000).
18. Whisenhunt, Jr, D. W., Heu, M. P., Hou, Z, Xu, J., Hoffman, D. C. and Raymond, K. N. Stability of the thorium(IV) complexes of desferrioxamine B (DFO) and three octadentate calecholate or hydroxypyridinonate DFO derivatives: DFOMTA, DFOCAMC, and DFO-1,2-HOPO. Comparative stability of the plutonium(IV) DFOMTA complex. Inorg. Chem. 35, 4128-4136 (1996).
19. Piskunov, E. M. and Rykov, A. G. Investigation of complex formation with diethylenetriaminepentaaectic acid: V. plutonium(IV). Radiokhimiya 14, 332-333 (1972). English Translation, Soviet Radiochemistry 14, 345-346.
20. Raymond, K. N., Harris, W. R., Carrano, C. J. and Weitl, F. W. The synthesis and thermodynamic behavior and biological properties of metal-ion-specific sequestering agents for iron and actinides. In: Inorganic chemistry in biology and medicine. Ed. A. E. Martell, pp. 413-432. ACS Symposium Series No 140 (Washington, DC: Americal Chemical Society) (1980).
21. Scarrow, R. C., Riley, P. E., Abu-Dari, K., White, D. L. and Raymond, K. N. Synthesis, structure, and thermodynamics of complexation of cobalt(III) and iron(III): tris complexes of several chelating hydroxypyridinones. Inorg. Chem. 24, 954-957 (1985).
22. Durbin, P. W., Kullgren, B., Xu, J., Raymond, K. N., Hengé-Napoli, M.-H., Bailly, T. and Burgada, R. Octadentate hydroxypyridinonate (HOPO) ligands for plutonium(IV): pharmacokinetics and oral efficacy. Radiat. Prot. Dosim. 105(1-4), 503-508 (This issue).
23. Baybarz, R. D. Dissociation constants of the transplutonium element chelates with diethylenetriaminepentaacetic acid (DTPA) and the application of DTPA chelates to solvent extraction separations of transplutonium elements from lanthanide elements. J. Inorg. Nucl. Chem. 27, 1831-1839 (1965).
24. Xu, J., Franklin, S. J., Whisenhunt, Jr. D.W. and Raymond, K. N. Gadolinium complex of tris[(3-hydroxy-1-methyl-2-oxo-1,2-didehydropyridine-4carboxamido)ethyl] amine: a new class of gadolinium magnetic resonance relaxation agents. J. Am. Chem. Soc. 117, 7245-7247 (1995).
25. Taylor, D. M. The eftects of desferrioxamine on the retention of actinide elements in the rat. Health Phys. 13, 135-140 (1967).
26. Volf. V. Chelation therapy of incorporated plutonium-238 and americium-241: comparison of LICAM(C), DTPA and DFOA in rats, hamsters and mice. Int. J. Radiat. Biol. 49, 449-462 (1986).